Duchenne Muscular Dystrophy (DMD)
3 competing products in clinical development for Duchenne Muscular Dystrophy (DMD).
Pipeline by Phase
Phase 11
Phase 1/22
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| ENTR-601-44 + ENTR-601-44 - matching placebo | Entrada Therapeutics | Phase 1/2 | Recruiting | 29 |
| ENTR-601-45 + ENTR-601-45 - matching placebo | Entrada Therapeutics | Phase 1/2 | Recruiting | 29 |
| Bocidelpar + Placebo | Astellas Pharma | Phase 1 | Terminated | 21 |